

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 9.20834340 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 9.20834340 |
| 3 | regulation of helicase activity (GO:0051095) | 5.54579141 |
| 4 | keratinocyte development (GO:0003334) | 5.45811538 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.09265969 |
| 6 | positive regulation of mitochondrial fission (GO:0090141) | 4.80713432 |
| 7 | arginine catabolic process (GO:0006527) | 4.69354533 |
| 8 | snRNA processing (GO:0016180) | 4.45435500 |
| 9 | regulation of sarcomere organization (GO:0060297) | 4.32652185 |
| 10 | snRNA metabolic process (GO:0016073) | 4.26831985 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.19912499 |
| 12 | viral protein processing (GO:0019082) | 4.18961428 |
| 13 | ether lipid metabolic process (GO:0046485) | 4.18707787 |
| 14 | negative regulation of DNA recombination (GO:0045910) | 4.10458188 |
| 15 | response to pheromone (GO:0019236) | 4.06213752 |
| 16 | GMP metabolic process (GO:0046037) | 4.02303957 |
| 17 | glial cell proliferation (GO:0014009) | 3.99127832 |
| 18 | lactate metabolic process (GO:0006089) | 3.98563887 |
| 19 | histone deubiquitination (GO:0016578) | 3.81087477 |
| 20 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.74971840 |
| 21 | pyrimidine dimer repair (GO:0006290) | 3.72323395 |
| 22 | positive T cell selection (GO:0043368) | 3.62226292 |
| 23 | ectodermal placode formation (GO:0060788) | 3.61721637 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.46917085 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.43687310 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43687310 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.43687310 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43687310 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43687310 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43687310 |
| 31 | cellular response to leptin stimulus (GO:0044320) | 3.38294014 |
| 32 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.37414779 |
| 33 | branched-chain amino acid catabolic process (GO:0009083) | 3.33734394 |
| 34 | COPII vesicle coating (GO:0048208) | 3.28430009 |
| 35 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.26966296 |
| 36 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.24373153 |
| 37 | removal of superoxide radicals (GO:0019430) | 3.21795213 |
| 38 | cellular response to superoxide (GO:0071451) | 3.21795213 |
| 39 | cellular response to oxygen radical (GO:0071450) | 3.21795213 |
| 40 | synaptic vesicle exocytosis (GO:0016079) | 3.21740172 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21700619 |
| 42 | regulation of mitochondrial fission (GO:0090140) | 3.17825682 |
| 43 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.17212415 |
| 44 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.11883844 |
| 45 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.11110942 |
| 46 | mitochondrial fusion (GO:0008053) | 3.09671424 |
| 47 | proteasome assembly (GO:0043248) | 3.07675735 |
| 48 | peroxisome fission (GO:0016559) | 3.07013452 |
| 49 | limb bud formation (GO:0060174) | 3.05301461 |
| 50 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.02557896 |
| 51 | histone H2A acetylation (GO:0043968) | 3.02474616 |
| 52 | eyelid development in camera-type eye (GO:0061029) | 3.02459043 |
| 53 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.01713333 |
| 54 | protein heterotetramerization (GO:0051290) | 3.01161886 |
| 55 | regulation of mitochondrial translation (GO:0070129) | 3.00241912 |
| 56 | mitochondrial RNA metabolic process (GO:0000959) | 3.00014721 |
| 57 | protein complex biogenesis (GO:0070271) | 2.98129716 |
| 58 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.97689408 |
| 59 | phagosome maturation (GO:0090382) | 2.94545272 |
| 60 | regulation of cofactor metabolic process (GO:0051193) | 2.94254448 |
| 61 | regulation of coenzyme metabolic process (GO:0051196) | 2.94254448 |
| 62 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.94020073 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.94020073 |
| 64 | positive regulation of glycolytic process (GO:0045821) | 2.93460713 |
| 65 | regulation of translation in response to stress (GO:0043555) | 2.89303237 |
| 66 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.89288678 |
| 67 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.89288678 |
| 68 | acrosome assembly (GO:0001675) | 2.87665620 |
| 69 | biotin metabolic process (GO:0006768) | 2.87560622 |
| 70 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84751663 |
| 71 | nitric oxide mediated signal transduction (GO:0007263) | 2.83936804 |
| 72 | peptidyl-histidine modification (GO:0018202) | 2.82243721 |
| 73 | short-chain fatty acid metabolic process (GO:0046459) | 2.81172928 |
| 74 | regulation of ruffle assembly (GO:1900027) | 2.80818702 |
| 75 | protein-chromophore linkage (GO:0018298) | 2.80059827 |
| 76 | rRNA methylation (GO:0031167) | 2.77647136 |
| 77 | heparin biosynthetic process (GO:0030210) | 2.77015702 |
| 78 | heparin metabolic process (GO:0030202) | 2.77015702 |
| 79 | neuron cell-cell adhesion (GO:0007158) | 2.76573227 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 2.74633179 |
| 81 | synaptic transmission, glutamatergic (GO:0035249) | 2.74531152 |
| 82 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.72444544 |
| 83 | cellular response to zinc ion (GO:0071294) | 2.72153184 |
| 84 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.71386949 |
| 85 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.71371031 |
| 86 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.70728874 |
| 87 | negative regulation of ligase activity (GO:0051352) | 2.70728874 |
| 88 | transferrin transport (GO:0033572) | 2.70672477 |
| 89 | response to nitrosative stress (GO:0051409) | 2.70223368 |
| 90 | response to leptin (GO:0044321) | 2.69590072 |
| 91 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.69139723 |
| 92 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.67488618 |
| 93 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.65484568 |
| 94 | nucleotide-excision repair, DNA damage removal (GO:0000718) | 2.63458660 |
| 95 | DNA excision (GO:0044349) | 2.63458660 |
| 96 | protein localization to cilium (GO:0061512) | 2.63243003 |
| 97 | synaptic vesicle endocytosis (GO:0048488) | 2.62384918 |
| 98 | ribonucleoprotein complex disassembly (GO:0032988) | 2.61182308 |
| 99 | branched-chain amino acid metabolic process (GO:0009081) | 2.61049778 |
| 100 | microglial cell activation (GO:0001774) | 2.60850349 |
| 101 | response to superoxide (GO:0000303) | 2.60352953 |
| 102 | COPI coating of Golgi vesicle (GO:0048205) | 2.60188790 |
| 103 | Golgi transport vesicle coating (GO:0048200) | 2.60188790 |
| 104 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.60144179 |
| 105 | striatum development (GO:0021756) | 2.59587168 |
| 106 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.58893481 |
| 107 | histone H4-K5 acetylation (GO:0043981) | 2.56845790 |
| 108 | histone H4-K8 acetylation (GO:0043982) | 2.56845790 |
| 109 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.56744321 |
| 110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56517877 |
| 111 | response to oxygen radical (GO:0000305) | 2.56366228 |
| 112 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.56348616 |
| 113 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.56259994 |
| 114 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.56259994 |
| 115 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.55589143 |
| 116 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.55589143 |
| 117 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.55589143 |
| 118 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.54854671 |
| 119 | negative regulation of translational initiation (GO:0045947) | 2.53927499 |
| 120 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.53288189 |
| 121 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.53159541 |
| 122 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.53159541 |
| 123 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52408477 |
| 124 | citrulline metabolic process (GO:0000052) | 2.52167021 |
| 125 | single strand break repair (GO:0000012) | 2.51996714 |
| 126 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.51533641 |
| 127 | Notch receptor processing (GO:0007220) | 2.51244263 |
| 128 | peptidyl-cysteine modification (GO:0018198) | 2.51185857 |
| 129 | positive regulation of protein homooligomerization (GO:0032464) | 2.50404126 |
| 130 | spermatid nucleus differentiation (GO:0007289) | 2.49362480 |
| 131 | rRNA modification (GO:0000154) | 2.48537104 |
| 132 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.48252132 |
| 133 | mitotic sister chromatid cohesion (GO:0007064) | 2.48245135 |
| 134 | ncRNA 3-end processing (GO:0043628) | 2.48229404 |
| 135 | cardiolipin metabolic process (GO:0032048) | 2.48212575 |
| 136 | aldehyde catabolic process (GO:0046185) | 2.48137227 |
| 137 | protein K11-linked ubiquitination (GO:0070979) | 2.47772079 |
| 138 | glucose 6-phosphate metabolic process (GO:0051156) | 2.47347741 |
| 139 | cellular response to glucose starvation (GO:0042149) | 2.47156823 |
| 140 | protein deneddylation (GO:0000338) | 2.46682639 |
| 141 | L-methionine biosynthetic process (GO:0071265) | 2.46526726 |
| 142 | amino acid salvage (GO:0043102) | 2.46526726 |
| 143 | L-methionine salvage (GO:0071267) | 2.46526726 |
| 144 | mitochondrial fission (GO:0000266) | 2.46382283 |
| 145 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.46062437 |
| 146 | heme transport (GO:0015886) | 2.45891340 |
| 147 | mRNA modification (GO:0016556) | 2.45551247 |
| 148 | positive regulation of isotype switching (GO:0045830) | 2.45409128 |
| 149 | purine-containing compound salvage (GO:0043101) | 2.45259071 |
| 150 | cytochrome complex assembly (GO:0017004) | 2.45248550 |
| 151 | cullin deneddylation (GO:0010388) | 2.44830969 |
| 152 | sympathetic nervous system development (GO:0048485) | 2.44646036 |
| 153 | cilium morphogenesis (GO:0060271) | 2.44321702 |
| 154 | nitric oxide biosynthetic process (GO:0006809) | 2.44226415 |
| 155 | negative regulation of stem cell proliferation (GO:2000647) | 2.43112310 |
| 156 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.42491550 |
| 157 | ferric iron transport (GO:0015682) | 2.41069771 |
| 158 | trivalent inorganic cation transport (GO:0072512) | 2.41069771 |
| 159 | B cell proliferation (GO:0042100) | 2.38661067 |
| 160 | negative T cell selection (GO:0043383) | 2.36647033 |
| 161 | negative thymic T cell selection (GO:0045060) | 2.34059284 |
| 162 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.33959440 |
| 163 | macrophage activation involved in immune response (GO:0002281) | 2.33413235 |
| 164 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.32744817 |
| 165 | positive thymic T cell selection (GO:0045059) | 2.32166827 |
| 166 | neuron recognition (GO:0008038) | 2.31582809 |
| 167 | T cell migration (GO:0072678) | 2.31170028 |
| 168 | neuron-neuron synaptic transmission (GO:0007270) | 2.27246902 |
| 169 | urinary tract smooth muscle contraction (GO:0014848) | 2.23546577 |
| 170 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.22201749 |
| 171 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.21960954 |
| 172 | positive regulation of DNA recombination (GO:0045911) | 2.21512526 |
| 173 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.21044863 |
| 174 | lymphocyte chemotaxis (GO:0048247) | 2.17504025 |
| 175 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.15860973 |
| 176 | hippocampus development (GO:0021766) | 2.15305716 |
| 177 | positive regulation of synapse assembly (GO:0051965) | 2.14568526 |
| 178 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.14222205 |
| 179 | inositol phosphate catabolic process (GO:0071545) | 2.13732397 |
| 180 | postsynaptic membrane organization (GO:0001941) | 2.13402036 |
| 181 | regulation of ARF protein signal transduction (GO:0032012) | 2.13249546 |
| 182 | histamine secretion (GO:0001821) | 2.13055073 |
| 183 | negative regulation of microtubule polymerization (GO:0031115) | 2.12739077 |
| 184 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.12713246 |
| 185 | neutrophil activation involved in immune response (GO:0002283) | 2.12648799 |
| 186 | lipopolysaccharide metabolic process (GO:0008653) | 2.11984818 |
| 187 | cardiovascular system development (GO:0072358) | 2.11570209 |
| 188 | positive regulation of humoral immune response (GO:0002922) | 2.09441186 |
| 189 | virion assembly (GO:0019068) | 2.08503278 |
| 190 | cyclic nucleotide catabolic process (GO:0009214) | 2.07572412 |
| 191 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.06780449 |
| 192 | metanephric mesenchyme development (GO:0072075) | 2.06685165 |
| 193 | cAMP catabolic process (GO:0006198) | 2.06478455 |
| 194 | protein localization to synapse (GO:0035418) | 2.05433179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 8.61928186 |
| 2 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.64841457 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.61072755 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54552136 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.45135694 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.40961786 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.40560900 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.36784130 |
| 9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.15030268 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.03275403 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.83003162 |
| 12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.79726675 |
| 13 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.77932442 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.71950485 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.54624148 |
| 16 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.37718393 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.37044498 |
| 18 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36379930 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.34851764 |
| 20 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.29515072 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.26923120 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.24979863 |
| 23 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.22119002 |
| 24 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.18222304 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.16420987 |
| 26 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.11606250 |
| 27 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.06245302 |
| 28 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.04519073 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00200013 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.95433574 |
| 31 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.91386826 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.89053661 |
| 33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.87388688 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87103399 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86654519 |
| 36 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86388498 |
| 37 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.84967899 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80099053 |
| 39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72095056 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71847516 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.70800561 |
| 42 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.70689471 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.70106056 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67421625 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.67360977 |
| 46 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65645620 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65054858 |
| 48 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.63923306 |
| 49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63077367 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.62751845 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61858398 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59089966 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.57957676 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55796403 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52181043 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49518598 |
| 57 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47517474 |
| 58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.46110798 |
| 59 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.44682988 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43988577 |
| 61 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.43868032 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42844965 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42744364 |
| 64 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41459282 |
| 65 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39972620 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39754375 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39231255 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39111382 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35137794 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33512394 |
| 71 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32058065 |
| 72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30871974 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.30699527 |
| 74 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30439763 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29784622 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.27899522 |
| 77 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.27869990 |
| 78 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27773718 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27700052 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27204154 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26753726 |
| 82 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24980679 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.24922294 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24267215 |
| 85 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23677045 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23518452 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22978464 |
| 88 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.22812185 |
| 89 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.19143780 |
| 90 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16772686 |
| 91 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14754484 |
| 92 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13851043 |
| 93 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.13776000 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.13746197 |
| 95 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.12341602 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11734773 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11299327 |
| 98 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10607004 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09921733 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09789307 |
| 101 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09428294 |
| 102 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.08571109 |
| 103 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07952913 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07434591 |
| 105 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.06642594 |
| 106 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06477868 |
| 107 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06463581 |
| 108 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06315417 |
| 109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06266971 |
| 110 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.06050475 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05330347 |
| 112 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04378590 |
| 113 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.04293809 |
| 114 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.03630109 |
| 115 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02293955 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01465393 |
| 117 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.00969219 |
| 118 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.00966267 |
| 119 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.00966267 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00675484 |
| 121 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00326232 |
| 122 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99936145 |
| 123 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98807327 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98621362 |
| 125 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98559440 |
| 126 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97816233 |
| 127 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97026269 |
| 128 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96674730 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95740096 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95709448 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95066086 |
| 132 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94646205 |
| 133 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.94328706 |
| 134 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93258951 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93257129 |
| 136 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.93080407 |
| 137 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93022402 |
| 138 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.92704760 |
| 139 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91497844 |
| 140 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90998794 |
| 141 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90691324 |
| 142 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90266340 |
| 143 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90089045 |
| 144 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90087624 |
| 145 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89923719 |
| 146 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.89906637 |
| 147 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89849005 |
| 148 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.89010760 |
| 149 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88884439 |
| 150 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87810117 |
| 151 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87746971 |
| 152 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87562313 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86616533 |
| 154 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.86405633 |
| 155 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.86301184 |
| 156 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85780460 |
| 157 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.85695138 |
| 158 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85412512 |
| 159 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85389198 |
| 160 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84907781 |
| 161 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84774098 |
| 162 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.84654317 |
| 163 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84180284 |
| 164 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83728926 |
| 165 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82592320 |
| 166 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.82516358 |
| 167 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.79822099 |
| 168 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.79258001 |
| 169 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78964373 |
| 170 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78319912 |
| 171 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.78073407 |
| 172 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.77875804 |
| 173 | EWS_26573619_Chip-Seq_HEK293_Human | 0.77387881 |
| 174 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77203933 |
| 175 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.75887362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 6.49566187 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.25530098 |
| 3 | MP0003221_abnormal_cardiomyocyte_apopto | 3.74398093 |
| 4 | MP0008995_early_reproductive_senescence | 3.37251350 |
| 5 | MP0003880_abnormal_central_pattern | 3.24203210 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.20400006 |
| 7 | MP0005646_abnormal_pituitary_gland | 3.05428469 |
| 8 | MP0006054_spinal_hemorrhage | 2.82367227 |
| 9 | MP0005499_abnormal_olfactory_system | 2.79646350 |
| 10 | MP0005394_taste/olfaction_phenotype | 2.79646350 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.71970522 |
| 12 | MP0004233_abnormal_muscle_weight | 2.69955846 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.63677998 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.61230758 |
| 15 | MP0008789_abnormal_olfactory_epithelium | 2.59743346 |
| 16 | MP0008058_abnormal_DNA_repair | 2.56260878 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.50127464 |
| 18 | MP0000015_abnormal_ear_pigmentation | 2.45555551 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.34210366 |
| 20 | MP0002822_catalepsy | 2.29302138 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 2.23656759 |
| 22 | MP0000372_irregular_coat_pigmentation | 2.17366180 |
| 23 | MP0003941_abnormal_skin_development | 2.14998700 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 2.03383358 |
| 25 | MP0001984_abnormal_olfaction | 2.01586984 |
| 26 | MP0005171_absent_coat_pigmentation | 2.00051652 |
| 27 | MP0003786_premature_aging | 1.94679387 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.93314554 |
| 29 | MP0002063_abnormal_learning/memory/cond | 1.85441409 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.82349170 |
| 31 | MP0002064_seizures | 1.80784428 |
| 32 | MP0001529_abnormal_vocalization | 1.79501554 |
| 33 | MP0004270_analgesia | 1.79369715 |
| 34 | MP0003122_maternal_imprinting | 1.78506133 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.78398607 |
| 36 | MP0000778_abnormal_nervous_system | 1.75183110 |
| 37 | MP0002234_abnormal_pharynx_morphology | 1.74367658 |
| 38 | MP0009840_abnormal_foam_cell | 1.67499119 |
| 39 | MP0002751_abnormal_autonomic_nervous | 1.66844271 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.66152105 |
| 41 | MP0003724_increased_susceptibility_to | 1.65449553 |
| 42 | MP0009046_muscle_twitch | 1.63238335 |
| 43 | MP0002572_abnormal_emotion/affect_behav | 1.61689267 |
| 44 | MP0002009_preneoplasia | 1.60621862 |
| 45 | MP0009697_abnormal_copulation | 1.59365888 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.58684329 |
| 47 | MP0003718_maternal_effect | 1.58224665 |
| 48 | MP0004858_abnormal_nervous_system | 1.56604001 |
| 49 | MP0009745_abnormal_behavioral_response | 1.56538179 |
| 50 | MP0002163_abnormal_gland_morphology | 1.56292462 |
| 51 | MP0010030_abnormal_orbit_morphology | 1.54742892 |
| 52 | MP0002272_abnormal_nervous_system | 1.51178055 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.49609702 |
| 54 | MP0006082_CNS_inflammation | 1.47757074 |
| 55 | MP0004134_abnormal_chest_morphology | 1.43720662 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.41681715 |
| 57 | MP0000920_abnormal_myelination | 1.40690965 |
| 58 | MP0008569_lethality_at_weaning | 1.37254061 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.35867946 |
| 60 | MP0003634_abnormal_glial_cell | 1.33549412 |
| 61 | MP0002736_abnormal_nociception_after | 1.33382946 |
| 62 | MP0001293_anophthalmia | 1.32062828 |
| 63 | MP0002184_abnormal_innervation | 1.31632336 |
| 64 | MP0001968_abnormal_touch/_nociception | 1.31494273 |
| 65 | MP0002697_abnormal_eye_size | 1.31156414 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.29898602 |
| 67 | MP0002557_abnormal_social/conspecific_i | 1.29866291 |
| 68 | MP0008007_abnormal_cellular_replicative | 1.27178677 |
| 69 | MP0009765_abnormal_xenobiotic_induced | 1.26768521 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.26010877 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.25177486 |
| 72 | MP0003890_abnormal_embryonic-extraembry | 1.18595671 |
| 73 | MP0008057_abnormal_DNA_replication | 1.18207537 |
| 74 | MP0004147_increased_porphyrin_level | 1.17421758 |
| 75 | MP0003787_abnormal_imprinting | 1.17408197 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.17181554 |
| 77 | MP0005193_abnormal_anterior_eye | 1.16637751 |
| 78 | MP0002254_reproductive_system_inflammat | 1.16013602 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.14590471 |
| 80 | MP0002127_abnormal_cardiovascular_syste | 1.12792252 |
| 81 | MP0002090_abnormal_vision | 1.12770588 |
| 82 | MP0002882_abnormal_neuron_morphology | 1.10873260 |
| 83 | MP0003111_abnormal_nucleus_morphology | 1.10558954 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 1.09994668 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 1.09320283 |
| 86 | MP0005367_renal/urinary_system_phenotyp | 1.09080638 |
| 87 | MP0000516_abnormal_urinary_system | 1.09080638 |
| 88 | MP0004924_abnormal_behavior | 1.08115484 |
| 89 | MP0005386_behavior/neurological_phenoty | 1.08115484 |
| 90 | MP0002095_abnormal_skin_pigmentation | 1.07323019 |
| 91 | MP0005423_abnormal_somatic_nervous | 1.05108355 |
| 92 | MP0003763_abnormal_thymus_physiology | 1.04221081 |
| 93 | MP0001324_abnormal_eye_pigmentation | 1.03035158 |
| 94 | MP0003121_genomic_imprinting | 1.01819599 |
| 95 | MP0001727_abnormal_embryo_implantation | 1.01618080 |
| 96 | MP0005671_abnormal_response_to | 1.01375672 |
| 97 | MP0003690_abnormal_glial_cell | 1.01220334 |
| 98 | MP0002233_abnormal_nose_morphology | 1.01125011 |
| 99 | MP0010386_abnormal_urinary_bladder | 1.01029491 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 1.00526343 |
| 101 | MP0008873_increased_physiological_sensi | 0.99342362 |
| 102 | MP0002269_muscular_atrophy | 0.99296088 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 0.98881273 |
| 104 | MP0008260_abnormal_autophagy | 0.97990116 |
| 105 | MP0001919_abnormal_reproductive_system | 0.97869792 |
| 106 | MP0001970_abnormal_pain_threshold | 0.97195048 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.96680116 |
| 108 | MP0002419_abnormal_innate_immunity | 0.95746545 |
| 109 | MP0000955_abnormal_spinal_cord | 0.95559113 |
| 110 | MP0001873_stomach_inflammation | 0.91291217 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.91050734 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.90447630 |
| 113 | MP0003938_abnormal_ear_development | 0.88347812 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.88332919 |
| 115 | MP0001905_abnormal_dopamine_level | 0.88271136 |
| 116 | MP0000751_myopathy | 0.87034865 |
| 117 | MP0002152_abnormal_brain_morphology | 0.85638274 |
| 118 | MP0005310_abnormal_salivary_gland | 0.84793878 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.84150870 |
| 120 | MP0002653_abnormal_ependyma_morphology | 0.83529901 |
| 121 | MP0004957_abnormal_blastocyst_morpholog | 0.83257823 |
| 122 | MP0002066_abnormal_motor_capabilities/c | 0.83256865 |
| 123 | MP0001915_intracranial_hemorrhage | 0.82286205 |
| 124 | MP0003448_altered_tumor_morphology | 0.80033482 |
| 125 | MP0000358_abnormal_cell_content/ | 0.79586522 |
| 126 | MP0002938_white_spotting | 0.79436257 |
| 127 | MP0009785_altered_susceptibility_to | 0.78683327 |
| 128 | MP0000598_abnormal_liver_morphology | 0.78617638 |
| 129 | MP0003943_abnormal_hepatobiliary_system | 0.78555539 |
| 130 | MP0005174_abnormal_tail_pigmentation | 0.78406884 |
| 131 | MP0003866_abnormal_defecation | 0.78262953 |
| 132 | MP0005379_endocrine/exocrine_gland_phen | 0.78232846 |
| 133 | MP0003755_abnormal_palate_morphology | 0.76896299 |
| 134 | MP0009703_decreased_birth_body | 0.76437693 |
| 135 | MP0000371_diluted_coat_color | 0.74155102 |
| 136 | MP0001486_abnormal_startle_reflex | 0.73444859 |
| 137 | MP0002229_neurodegeneration | 0.73254144 |
| 138 | MP0002405_respiratory_system_inflammati | 0.73211877 |
| 139 | MP0001835_abnormal_antigen_presentation | 0.73211075 |
| 140 | MP0001270_distended_abdomen | 0.71792671 |
| 141 | MP0000490_abnormal_crypts_of | 0.71640393 |
| 142 | MP0003186_abnormal_redox_activity | 0.70861098 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.70756345 |
| 144 | MP0000049_abnormal_middle_ear | 0.70754891 |
| 145 | MP0003879_abnormal_hair_cell | 0.69832252 |
| 146 | MP0001819_abnormal_immune_cell | 0.69384325 |
| 147 | MP0002420_abnormal_adaptive_immunity | 0.68432837 |
| 148 | MP0004142_abnormal_muscle_tone | 0.68184966 |
| 149 | MP0005000_abnormal_immune_tolerance | 0.68033678 |
| 150 | MP0002148_abnormal_hypersensitivity_rea | 0.67500900 |
| 151 | MP0000026_abnormal_inner_ear | 0.67301365 |
| 152 | MP0001243_abnormal_dermal_layer | 0.67009121 |
| 153 | MP0005408_hypopigmentation | 0.66682997 |
| 154 | MP0001501_abnormal_sleep_pattern | 0.66122857 |
| 155 | MP0003935_abnormal_craniofacial_develop | 0.66118280 |
| 156 | MP0001986_abnormal_taste_sensitivity | 0.65737241 |
| 157 | MP0000858_altered_metastatic_potential | 0.65091320 |
| 158 | MP0000681_abnormal_thyroid_gland | 0.64961316 |
| 159 | MP0002396_abnormal_hematopoietic_system | 0.64004026 |
| 160 | MP0004133_heterotaxia | 0.63994652 |
| 161 | MP0006036_abnormal_mitochondrial_physio | 0.63901291 |
| 162 | MP0005248_abnormal_Harderian_gland | 0.63486609 |
| 163 | MP0005501_abnormal_skin_physiology | 0.63026984 |
| 164 | MP0002177_abnormal_outer_ear | 0.61477650 |
| 165 | MP0002080_prenatal_lethality | 0.60146392 |
| 166 | MP0005395_other_phenotype | 0.60048143 |
| 167 | MP0001764_abnormal_homeostasis | 0.59663977 |
| 168 | MP0002282_abnormal_trachea_morphology | 0.58634857 |
| 169 | MP0005464_abnormal_platelet_physiology | 0.58445454 |
| 170 | MP0003191_abnormal_cellular_cholesterol | 0.58418722 |
| 171 | MP0008872_abnormal_physiological_respon | 0.58376871 |
| 172 | MP0004185_abnormal_adipocyte_glucose | 0.58262984 |
| 173 | MP0002092_abnormal_eye_morphology | 0.57677246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.37575475 |
| 2 | Progressive cerebellar ataxia (HP:0002073) | 4.56072390 |
| 3 | Neuroendocrine neoplasm (HP:0100634) | 3.99217236 |
| 4 | Insidious onset (HP:0003587) | 3.82103922 |
| 5 | Termporal pattern (HP:0011008) | 3.82103922 |
| 6 | Medulloblastoma (HP:0002885) | 3.74690325 |
| 7 | True hermaphroditism (HP:0010459) | 3.72277364 |
| 8 | Central scotoma (HP:0000603) | 3.65014526 |
| 9 | Ketoacidosis (HP:0001993) | 3.58745547 |
| 10 | Albinism (HP:0001022) | 3.56831875 |
| 11 | Pheochromocytoma (HP:0002666) | 3.53204217 |
| 12 | Progressive sensorineural hearing impairment (HP:0000408) | 3.43653955 |
| 13 | Peritonitis (HP:0002586) | 3.35593320 |
| 14 | Pancreatic cysts (HP:0001737) | 3.23867008 |
| 15 | Gait imbalance (HP:0002141) | 3.21695332 |
| 16 | Optic neuritis (HP:0100653) | 3.19931113 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.19931113 |
| 18 | Intestinal atresia (HP:0011100) | 3.17812577 |
| 19 | Cortical dysplasia (HP:0002539) | 3.15342007 |
| 20 | Aplastic anemia (HP:0001915) | 3.10370855 |
| 21 | Myositis (HP:0100614) | 3.02907010 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.02895010 |
| 23 | Congenital primary aphakia (HP:0007707) | 3.01376559 |
| 24 | Sensory axonal neuropathy (HP:0003390) | 2.99400692 |
| 25 | Curly hair (HP:0002212) | 2.98762066 |
| 26 | Methylmalonic acidemia (HP:0002912) | 2.98049812 |
| 27 | Hyperglycinemia (HP:0002154) | 2.97996178 |
| 28 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.92161423 |
| 29 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.92161423 |
| 30 | Ependymoma (HP:0002888) | 2.91947778 |
| 31 | Medial flaring of the eyebrow (HP:0010747) | 2.87112832 |
| 32 | * Nephrogenic diabetes insipidus (HP:0009806) | 2.83958345 |
| 33 | Hypoplasia of the fovea (HP:0007750) | 2.83242273 |
| 34 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.83242273 |
| 35 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.81083434 |
| 36 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.81083434 |
| 37 | Increased serum pyruvate (HP:0003542) | 2.77759261 |
| 38 | Abnormality of glycolysis (HP:0004366) | 2.77759261 |
| 39 | Hyperammonemia (HP:0001987) | 2.76574280 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.73492897 |
| 41 | Hypoglycemic seizures (HP:0002173) | 2.70756522 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.69328213 |
| 43 | Neoplasm of the oral cavity (HP:0100649) | 2.67742904 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.62672519 |
| 45 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60727672 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.60727672 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59258243 |
| 48 | Focal motor seizures (HP:0011153) | 2.56757577 |
| 49 | Orchitis (HP:0100796) | 2.55641652 |
| 50 | Tinnitus (HP:0000360) | 2.55561712 |
| 51 | Split foot (HP:0001839) | 2.54531734 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52394041 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52394041 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52394041 |
| 55 | Epidermoid cyst (HP:0200040) | 2.47748656 |
| 56 | Atonic seizures (HP:0010819) | 2.46684594 |
| 57 | Prominent metopic ridge (HP:0005487) | 2.46559591 |
| 58 | Myelodysplasia (HP:0002863) | 2.44319113 |
| 59 | Broad alveolar ridges (HP:0000187) | 2.43560334 |
| 60 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.43477847 |
| 61 | Dyschromatopsia (HP:0007641) | 2.43349420 |
| 62 | Abnormality of alanine metabolism (HP:0010916) | 2.42160359 |
| 63 | Hyperalaninemia (HP:0003348) | 2.42160359 |
| 64 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.42160359 |
| 65 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.40642079 |
| 66 | Ketosis (HP:0001946) | 2.39714721 |
| 67 | Epileptic encephalopathy (HP:0200134) | 2.39381870 |
| 68 | Poor coordination (HP:0002370) | 2.37116277 |
| 69 | Recurrent abscess formation (HP:0002722) | 2.36556517 |
| 70 | Abnormal hair whorl (HP:0010721) | 2.36303588 |
| 71 | Scotoma (HP:0000575) | 2.36221515 |
| 72 | Abnormal auditory evoked potentials (HP:0006958) | 2.36080247 |
| 73 | Abnormality of the fovea (HP:0000493) | 2.35677416 |
| 74 | Fatigue (HP:0012378) | 2.34375347 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.33202869 |
| 76 | Symptomatic seizures (HP:0011145) | 2.32535221 |
| 77 | Entropion (HP:0000621) | 2.32341759 |
| 78 | Hepatoblastoma (HP:0002884) | 2.32113129 |
| 79 | Specific learning disability (HP:0001328) | 2.31047320 |
| 80 | Progressive hearing impairment (HP:0001730) | 2.28297725 |
| 81 | Abnormality of the corticospinal tract (HP:0002492) | 2.26598557 |
| 82 | Microretrognathia (HP:0000308) | 2.25312962 |
| 83 | Hypokinesia (HP:0002375) | 2.25045397 |
| 84 | Abnormality of the metopic suture (HP:0005556) | 2.24607801 |
| 85 | Vaginal atresia (HP:0000148) | 2.21450621 |
| 86 | Abnormal lung lobation (HP:0002101) | 2.21295030 |
| 87 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.20449897 |
| 88 | Embryonal renal neoplasm (HP:0011794) | 2.16615219 |
| 89 | Delayed CNS myelination (HP:0002188) | 2.15990901 |
| 90 | Genital tract atresia (HP:0001827) | 2.15012446 |
| 91 | Renal Fanconi syndrome (HP:0001994) | 2.13409965 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12568200 |
| 93 | Thyroid carcinoma (HP:0002890) | 2.12229245 |
| 94 | Limb dystonia (HP:0002451) | 2.11551523 |
| 95 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.11298542 |
| 96 | Type I transferrin isoform profile (HP:0003642) | 2.10035718 |
| 97 | Astrocytoma (HP:0009592) | 2.09313048 |
| 98 | Abnormality of the astrocytes (HP:0100707) | 2.09313048 |
| 99 | Hypoglycemic coma (HP:0001325) | 2.08916524 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 2.08821799 |
| 101 | Hyperglycinuria (HP:0003108) | 2.06512016 |
| 102 | Hand muscle atrophy (HP:0009130) | 2.05849188 |
| 103 | Neoplasm of the adrenal gland (HP:0100631) | 2.04967047 |
| 104 | Increased hepatocellular lipid droplets (HP:0006565) | 2.04351130 |
| 105 | Abnormality of the labia minora (HP:0012880) | 2.02771286 |
| 106 | Microvesicular hepatic steatosis (HP:0001414) | 2.00765395 |
| 107 | Progressive inability to walk (HP:0002505) | 2.00552878 |
| 108 | Delusions (HP:0000746) | 2.00414347 |
| 109 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99891862 |
| 110 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99064070 |
| 111 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99064070 |
| 112 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.98222127 |
| 113 | Annular pancreas (HP:0001734) | 1.97827129 |
| 114 | Neonatal respiratory distress (HP:0002643) | 1.97746940 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 1.96949718 |
| 116 | Loss of speech (HP:0002371) | 1.96702167 |
| 117 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.96431177 |
| 118 | Villous atrophy (HP:0011473) | 1.96431177 |
| 119 | Agnosia (HP:0010524) | 1.94653848 |
| 120 | Hypoplastic left heart (HP:0004383) | 1.94440376 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 1.94268104 |
| 122 | T lymphocytopenia (HP:0005403) | 1.93109154 |
| 123 | Cerebral hypomyelination (HP:0006808) | 1.92115294 |
| 124 | Increased IgM level (HP:0003496) | 1.92049327 |
| 125 | Abnormality of methionine metabolism (HP:0010901) | 1.91112955 |
| 126 | Leukocytosis (HP:0001974) | 1.91110538 |
| 127 | Urinary urgency (HP:0000012) | 1.89358023 |
| 128 | Long clavicles (HP:0000890) | 1.89349340 |
| 129 | Abnormal pancreas size (HP:0012094) | 1.89059329 |
| 130 | Abnormality of the vocal cords (HP:0008777) | 1.88581066 |
| 131 | Mutism (HP:0002300) | 1.88295719 |
| 132 | Irregular vertebral endplates (HP:0003301) | 1.87842133 |
| 133 | Shoulder girdle muscle weakness (HP:0003547) | 1.87612107 |
| 134 | Bifid tongue (HP:0010297) | 1.86318636 |
| 135 | Failure to thrive in infancy (HP:0001531) | 1.85016667 |
| 136 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.84093392 |
| 137 | Abnormality of lateral ventricle (HP:0030047) | 1.83472301 |
| 138 | Cavernous hemangioma (HP:0001048) | 1.82982652 |
| 139 | Febrile seizures (HP:0002373) | 1.81521613 |
| 140 | Poor head control (HP:0002421) | 1.80391923 |
| 141 | Hepatocellular necrosis (HP:0001404) | 1.80309693 |
| 142 | Uterine leiomyosarcoma (HP:0002891) | 1.80252023 |
| 143 | Leiomyosarcoma (HP:0100243) | 1.80252023 |
| 144 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.80156037 |
| 145 | Muscular hypotonia of the trunk (HP:0008936) | 1.80001369 |
| 146 | Progressive external ophthalmoplegia (HP:0000590) | 1.79611095 |
| 147 | Abnormality of serum amino acid levels (HP:0003112) | 1.79256863 |
| 148 | Acute necrotizing encephalopathy (HP:0006965) | 1.78753060 |
| 149 | Amaurosis fugax (HP:0100576) | 1.76971254 |
| 150 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76905190 |
| 151 | Broad foot (HP:0001769) | 1.76266033 |
| 152 | Focal seizures (HP:0007359) | 1.76023797 |
| 153 | Generalized hypopigmentation (HP:0007513) | 1.74723552 |
| 154 | Cone-rod dystrophy (HP:0000548) | 1.74686354 |
| 155 | Papillary thyroid carcinoma (HP:0002895) | 1.74328774 |
| 156 | Polyphagia (HP:0002591) | 1.74017076 |
| 157 | Hypertensive crisis (HP:0100735) | 1.72780758 |
| 158 | Hypoplastic pelvis (HP:0008839) | 1.72146329 |
| 159 | Volvulus (HP:0002580) | 1.71966753 |
| 160 | Heterochromia iridis (HP:0001100) | 1.71674671 |
| 161 | Poikiloderma (HP:0001029) | 1.71022567 |
| 162 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.70284956 |
| 163 | Neuroblastic tumors (HP:0004376) | 1.69863212 |
| 164 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.69863212 |
| 165 | Neuroblastoma (HP:0003006) | 1.69863212 |
| 166 | Primitive neuroectodermal tumor (HP:0030065) | 1.69863212 |
| 167 | Diastasis recti (HP:0001540) | 1.69754482 |
| 168 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69656584 |
| 169 | Abnormality of T cell number (HP:0011839) | 1.69115262 |
| 170 | Acrocyanosis (HP:0001063) | 1.68607629 |
| 171 | Degeneration of anterior horn cells (HP:0002398) | 1.67944131 |
| 172 | Abnormality of the anterior horn cell (HP:0006802) | 1.67944131 |
| 173 | Glioma (HP:0009733) | 1.67908464 |
| 174 | Hypothermia (HP:0002045) | 1.67883878 |
| 175 | Recurrent skin infections (HP:0001581) | 1.67771121 |
| 176 | Hyperventilation (HP:0002883) | 1.67632852 |
| 177 | Popliteal pterygium (HP:0009756) | 1.66921100 |
| 178 | Vasculitis (HP:0002633) | 1.66565489 |
| 179 | Blue irides (HP:0000635) | 1.66513743 |
| 180 | Deep philtrum (HP:0002002) | 1.64399638 |
| 181 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.64185578 |
| 182 | Supranuclear gaze palsy (HP:0000605) | 1.63700580 |
| 183 | Single umbilical artery (HP:0001195) | 1.63255968 |
| 184 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.63255968 |
| 185 | Colon cancer (HP:0003003) | 1.62929936 |
| 186 | Anencephaly (HP:0002323) | 1.58731157 |
| 187 | Visual hallucinations (HP:0002367) | 1.58561293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 7.95361842 |
| 2 | NUAK1 | 4.65220359 |
| 3 | MARK1 | 2.90013393 |
| 4 | BCKDK | 2.82908302 |
| 5 | PLK2 | 2.65556945 |
| 6 | CCNB1 | 2.58206426 |
| 7 | DYRK1B | 2.35367740 |
| 8 | PRPF4B | 2.34702877 |
| 9 | CASK | 2.34062064 |
| 10 | MAP3K12 | 2.31632386 |
| 11 | MAPK13 | 2.28371464 |
| 12 | SIK3 | 2.22257342 |
| 13 | DAPK1 | 2.20392331 |
| 14 | TNIK | 2.17996791 |
| 15 | SGK2 | 2.14850571 |
| 16 | TSSK6 | 2.04085728 |
| 17 | VRK2 | 1.94672927 |
| 18 | SGK494 | 1.94105370 |
| 19 | SGK223 | 1.94105370 |
| 20 | MAP3K3 | 1.79867273 |
| 21 | NTRK3 | 1.67819593 |
| 22 | MINK1 | 1.63502105 |
| 23 | NME2 | 1.63185224 |
| 24 | BCR | 1.62373858 |
| 25 | RPS6KA4 | 1.62300763 |
| 26 | IRAK4 | 1.56841972 |
| 27 | MAP4K2 | 1.53210858 |
| 28 | MAP3K2 | 1.51527493 |
| 29 | MAP3K11 | 1.49225088 |
| 30 | KSR1 | 1.48235191 |
| 31 | DYRK2 | 1.48005952 |
| 32 | YES1 | 1.47962836 |
| 33 | STK38L | 1.43503727 |
| 34 | TAF1 | 1.43440613 |
| 35 | SRPK1 | 1.36372352 |
| 36 | LMTK2 | 1.32817803 |
| 37 | OXSR1 | 1.32433343 |
| 38 | EPHA4 | 1.31006651 |
| 39 | VRK1 | 1.29943665 |
| 40 | MAP2K7 | 1.29155418 |
| 41 | FES | 1.28193363 |
| 42 | NME1 | 1.26469524 |
| 43 | UHMK1 | 1.25985595 |
| 44 | CSNK1A1L | 1.25794157 |
| 45 | CSNK1G3 | 1.25134415 |
| 46 | CAMKK1 | 1.24226360 |
| 47 | LIMK1 | 1.23514072 |
| 48 | DAPK2 | 1.19302948 |
| 49 | STK10 | 1.19067633 |
| 50 | PNCK | 1.18209961 |
| 51 | RPS6KA2 | 1.16304718 |
| 52 | FLT3 | 1.15779647 |
| 53 | INSRR | 1.15681641 |
| 54 | ERBB3 | 1.11935786 |
| 55 | STK16 | 1.11009378 |
| 56 | PLK3 | 1.10497730 |
| 57 | MAPKAPK5 | 1.09873021 |
| 58 | ITK | 1.09716029 |
| 59 | CAMKK2 | 1.07244071 |
| 60 | MKNK1 | 1.07182467 |
| 61 | PKN2 | 1.06415563 |
| 62 | CAMK2B | 1.03255635 |
| 63 | CSNK1G2 | 1.03185435 |
| 64 | WNK3 | 1.00972885 |
| 65 | SGK3 | 1.00768477 |
| 66 | CDK19 | 0.97369143 |
| 67 | BMPR2 | 0.96010481 |
| 68 | KIT | 0.92640360 |
| 69 | TESK1 | 0.88438629 |
| 70 | FER | 0.87730224 |
| 71 | MST4 | 0.86826947 |
| 72 | EIF2AK3 | 0.86629513 |
| 73 | CDK5 | 0.84633387 |
| 74 | PRKCE | 0.80883277 |
| 75 | STK38 | 0.80621912 |
| 76 | PBK | 0.78266873 |
| 77 | DYRK1A | 0.77146251 |
| 78 | BRSK2 | 0.76775673 |
| 79 | ACVR1B | 0.75971028 |
| 80 | CDK6 | 0.75176190 |
| 81 | NTRK2 | 0.73879082 |
| 82 | TTK | 0.73673208 |
| 83 | RAF1 | 0.73572273 |
| 84 | TBK1 | 0.73424158 |
| 85 | CSNK1A1 | 0.72802732 |
| 86 | BRD4 | 0.71890469 |
| 87 | LRRK2 | 0.71649597 |
| 88 | PTK2B | 0.70800286 |
| 89 | NEK9 | 0.69695298 |
| 90 | PIM2 | 0.69562518 |
| 91 | CDK9 | 0.68530639 |
| 92 | ADRBK2 | 0.68513308 |
| 93 | CSK | 0.68253843 |
| 94 | FGR | 0.67623309 |
| 95 | SYK | 0.67317212 |
| 96 | ZAK | 0.65009018 |
| 97 | CSNK1G1 | 0.64751545 |
| 98 | EIF2AK1 | 0.63529367 |
| 99 | HIPK2 | 0.62673036 |
| 100 | TLK1 | 0.62564488 |
| 101 | CSF1R | 0.62516946 |
| 102 | MAP2K1 | 0.60379724 |
| 103 | MAP3K4 | 0.60034076 |
| 104 | CAMK2A | 0.59769065 |
| 105 | MAP2K6 | 0.58586487 |
| 106 | IRAK3 | 0.58482942 |
| 107 | AKT3 | 0.57840349 |
| 108 | RPS6KA6 | 0.57277341 |
| 109 | RPS6KC1 | 0.57185549 |
| 110 | RPS6KL1 | 0.57185549 |
| 111 | PASK | 0.57056300 |
| 112 | KSR2 | 0.56609656 |
| 113 | PRKCG | 0.55957454 |
| 114 | PRKCD | 0.55714652 |
| 115 | MAPK9 | 0.55618104 |
| 116 | ROCK2 | 0.55105910 |
| 117 | FYN | 0.54604255 |
| 118 | SCYL2 | 0.54039667 |
| 119 | PRKCH | 0.53123537 |
| 120 | PRKCB | 0.52251967 |
| 121 | CHEK1 | 0.51989262 |
| 122 | RIPK4 | 0.50296702 |
| 123 | PRKD2 | 0.49764636 |
| 124 | STK4 | 0.49758260 |
| 125 | PKN1 | 0.49683230 |
| 126 | PAK4 | 0.49606061 |
| 127 | ERBB4 | 0.49397391 |
| 128 | ILK | 0.47196753 |
| 129 | ATM | 0.46881663 |
| 130 | SGK1 | 0.46820241 |
| 131 | BMPR1B | 0.45577433 |
| 132 | RPS6KB1 | 0.43325464 |
| 133 | MATK | 0.43083489 |
| 134 | BUB1 | 0.43001871 |
| 135 | NEK6 | 0.41871961 |
| 136 | CDK7 | 0.41198480 |
| 137 | TNK2 | 0.40840045 |
| 138 | DYRK3 | 0.40751648 |
| 139 | BTK | 0.40413202 |
| 140 | MAP2K2 | 0.39799656 |
| 141 | FGFR1 | 0.39662278 |
| 142 | JAK2 | 0.39331675 |
| 143 | CAMK4 | 0.38938717 |
| 144 | CDK3 | 0.38780766 |
| 145 | CDK14 | 0.37768723 |
| 146 | PIM1 | 0.37731575 |
| 147 | CDK18 | 0.37635764 |
| 148 | TGFBR2 | 0.37075347 |
| 149 | MAP3K14 | 0.35393934 |
| 150 | PAK6 | 0.35152911 |
| 151 | PRKACB | 0.34639505 |
| 152 | PLK1 | 0.33344156 |
| 153 | PRKAA2 | 0.32925954 |
| 154 | AKT2 | 0.32687520 |
| 155 | CSNK1E | 0.32609600 |
| 156 | CAMK1G | 0.32042685 |
| 157 | EPHB2 | 0.31115826 |
| 158 | TAOK1 | 0.30850872 |
| 159 | CSNK1D | 0.29562348 |
| 160 | MAP3K5 | 0.29384759 |
| 161 | CSNK2A2 | 0.28631320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.16612429 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.25903715 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18057323 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.71500565 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.66120662 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64663802 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.64387536 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62697869 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.52383709 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.18745597 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.17816295 |
| 12 | Basal transcription factors_Homo sapiens_hsa03022 | 2.09019110 |
| 13 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.98959676 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.94419886 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.90742483 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.87425308 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83702189 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.80299727 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68363800 |
| 20 | Proteasome_Homo sapiens_hsa03050 | 1.66181006 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.65933818 |
| 22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.65093580 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.61684219 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.57313474 |
| 25 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.54982426 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54476108 |
| 27 | RNA transport_Homo sapiens_hsa03013 | 1.54108185 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48559215 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.46567681 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.45357793 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45326687 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.43588003 |
| 33 | Colorectal cancer_Homo sapiens_hsa05210 | 1.43568422 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.39907678 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39290028 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39229444 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.37051999 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36115299 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.35039124 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34825222 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.33712479 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32530277 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31160327 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29953173 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28761753 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.26658862 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25751151 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.24516813 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23805885 |
| 50 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.23634289 |
| 51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22640522 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22233898 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20445990 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.20102806 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19493697 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 1.13786795 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13389670 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13277575 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13155542 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11541456 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04670362 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 1.01923335 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.00994804 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00298829 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99393211 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98797103 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.98185343 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97805438 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97783601 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.97273231 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96871628 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.96180650 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94979955 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94931164 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94762743 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93874307 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.92839875 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.92439261 |
| 79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91560586 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.89909712 |
| 81 | DNA replication_Homo sapiens_hsa03030 | 0.88101920 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86996498 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86172101 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.86146926 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85873855 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85027005 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84365083 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83190421 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82161676 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.81406149 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.80930772 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78320667 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78252621 |
| 94 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77842168 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76727474 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76721851 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75047893 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74746312 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74453551 |
| 100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74214232 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.73538767 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73357682 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.72297319 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71226982 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70448032 |
| 106 | Mismatch repair_Homo sapiens_hsa03430 | 0.69307407 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.69302908 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.68673623 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67747980 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67568589 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65463961 |
| 112 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64823812 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63712461 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63622388 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62585457 |
| 116 | RNA degradation_Homo sapiens_hsa03018 | 0.62053553 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61744718 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61356676 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.61183168 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60849629 |
| 121 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60486443 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59820721 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59328912 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59237489 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58916549 |
| 126 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58043415 |
| 127 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57727251 |
| 128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57537562 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.56599629 |
| 130 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56013652 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55755905 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55458254 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55013100 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54567911 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54423113 |
| 136 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53956583 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53724335 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52607674 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52203404 |
| 140 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51424977 |
| 141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50267681 |
| 142 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49178065 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46929103 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.46262338 |
| 145 | Hepatitis B_Homo sapiens_hsa05161 | 0.45901369 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45519882 |
| 147 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45405765 |
| 148 | Glioma_Homo sapiens_hsa05214 | 0.44550497 |
| 149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43872219 |
| 150 | Long-term depression_Homo sapiens_hsa04730 | 0.43539038 |
| 151 | Influenza A_Homo sapiens_hsa05164 | 0.43162790 |
| 152 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43101943 |
| 153 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41443436 |
| 154 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41284663 |
| 155 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40516894 |
| 156 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39556387 |
| 157 | Homologous recombination_Homo sapiens_hsa03440 | 0.38171361 |
| 158 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37863620 |
| 159 | Base excision repair_Homo sapiens_hsa03410 | 0.37792513 |
| 160 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36848530 |
| 161 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31836467 |
| 162 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29429550 |
| 163 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28525372 |
| 164 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24252066 |

